Macro Voices
Macro Voices

MacroVoices #246 Daniel Lacalle: U.S. Election, European Outlook & More

MacroVoices Erik Townsend and Patrick Ceresna welcome Daniel Lacalle to the show to discuss what’s holding the stock market up as the vaccine news is offset by a marked increase in cases and deaths, bond yields, inflation, and much more. Link: https://bit.ly/3pUMwa6

Featured Speakers

Hedge Fund Manager Erik Townsend ([email protected]) HostEric Townsend GuestDaniel LaCalle Guest

Topics Discussed

Episode Summary

Executive Summary: Macro Voices episode 246 centers on the gap between near-term COVID-19 deterioration and the market’s vaccine-driven optimism. Eric Townsend and Daniel LaCalle argue that vaccines are positive but unlikely to materially change daily life until late 2021, while stimulus expectations, yield suppression, and policy shifts remain the dominant macro drivers. They also debate inflation, ECB fragility, China policy under Biden, fracking, and why gold, the dollar, crude, and yields sit near key inflection points.

Main Topics: Vaccine optimism vs. worsening pandemic reality (Priority: 5/5): Eric and Daniel agree vaccine news is genuinely positive, but insist markets are discounting a long distribution timeline while cases, hospitalizations, and deaths are rising sharply now. They expect more economic weakness and possible lockdowns before meaningful vaccine impact arrives. Equity market resilience and stimulus expectations (Priority: 5/5): The S&P 500’s strength is attributed less to immediate economic improvement and more to anticipation of fiscal and monetary stimulus, plus the market’s tendency to buy on any positive headline. Daniel argues investors are repeatedly discounting the same news flow. Dollar, gold, and inflation trade setup (Priority: 4/5): Eric frames both the U.S. dollar and gold as sitting at the bottom of their ranges, with gold viewed as a simpler long than trading fiat-to-fiat dollar moves. The discussion highlights potential correction risk in gold but a bullish long-term case tied to future monetary debasement. Crude oil and commodity positioning (Priority: 4/5): Crude is holding near the top of its range on front-month optimism tied to vaccines, despite inventory data and near-term demand concerns. Patrick’s chartbook suggests commodities broadly are testing resistance and may need a breakout or retracement soon. Rates, financial repression, and the end of the bond bull market (Priority: 5/5): Both guests see the long-duration bond trade as largely exhausted. Daniel argues central banks are suppressing yields through financial repression, but that the regime can’t last indefinitely once inflation and currency-demand dynamics shift. Inflation, stagflation, and monetary policy limits (Priority: 5/5): Daniel argues current policy creates asset-price inflation and squeezes lower-income households while official CPI stays subdued. He sees rising stagflation risk, but believes aggressive deflation likely comes first as debt saturation slows growth. ECB fragility, European periphery debt, and structural reform (Priority: 4/5): Daniel says ECB bond-buying has become an excuse for governments to avoid reforms, especially in southern Europe. He warns the euro system could face tension if peripheral sovereigns rely on support without improving productivity and solvency. Biden policy, China, Russia, and U.S. fracking (Priority: 4/5): Daniel expects a Biden administration to resemble the Obama era on China—more permissive toward Chinese trade and currency policy. He also argues Biden can’t credibly ban fracking without harming jobs, energy transition goals, and U.S. competitiveness.

Key Arguments: Markets are buying vaccine headlines, but the true economic benefit likely arrives only in the second half of 2021, not immediately. Current COVID metrics are still worsening, which means near-term lockdown risk and weaker growth remain live threats. The S&P 500 is being supported by stimulus expectations and the market’s willingness to pay for future recovery, not by present fundamentals. The U.S. dollar is weak against hard assets; trading the dollar index is less attractive than simply being long gold. Crude oil strength is front-loaded optimism; near-term demand may soften before vaccines improve conditions later in 2021. Gold remains a strategic hedge against fiat debasement, though a technical correction lower is possible if vaccine and election uncertainty resolve. Long-duration bonds have likely already delivered the big trade; rates may bottom without immediately reversing in a straight line. Central banks are creating financial repression and asset inflation, while true consumer inflation is less visible in official data but felt in living costs. The ECB’s support for peripheral Europe risks undermining reform incentives and could create core-periphery political stress. A Biden administration is likely to be softer on China and may continue policies that export deflation and pressure U.S. manufacturers. Fracking is portrayed as essential to a competitive U.S. energy transition because it supports natural gas, jobs, and low utility costs.

Data Points: Episode date: November 19, 2020 - Macro Voices episode 246 recording date S&P 500 level: around 3,600 - Market pinned near option-expiration resistance/support U.S. dollar index: just above 92 - Dollar trading near the bottom of its range Gold price: around 1,864 - Gold hovering near the same level as the prior week Gold intraday low: 1,850 - Repeated technical support level tested multiple times Gold 200-day moving average: 1,805 - Intermediate technical support mentioned in the interview Potential lower gold support: 1,757 - Further downside level if 1,850 breaks decisively 10-year Treasury yield: about 0.90% - Yield level cited during the interview as the recent high Crude oil price: around 42 - Front-month crude near the top of its trading range Crude oil inventory change: +768,000 barrels - Weekly U.S. crude inventory build instead of expected draw Cushing inventory change: +1.2 million barrels - Inventory build at Cushing, Oklahoma Gasoline inventory change: -2.6 million barrels - Weekly draw in gasoline inventories Distillates inventory change: -5.2 million barrels - Weekly draw in distillate inventories U.S. production: 10.9 million barrels/day - Oil output reported as rising U.S. production change: +400,000 barrels/day - Weekly increase in domestic production Moderna vaccine efficacy: 94% - Latest vaccine news referenced by Daniel LaCalle Pfizer vaccine efficacy: about 95% - Earlier vaccine headline discussed by Eric and Daniel Gold Pass minimum amount: as little as $1 worth of gold - Sponsor promotion for the Perth Mint app Potential 2021 vaccine access estimate: less than 38% of the at-risk population by end-2021 - Daniel’s cited estimate for broad access European GDP declines cited: Spain 7%-12% and similar severe declines - Daniel references sharp contractions in peripheral Europe

Pivotal Quotes: "“The vaccine news really is terrific news, but it's news about things that are likely to take about a year or so to play out.”" — Eric Townsend: On why vaccine optimism should not be treated as immediate economic recovery "“Things will get worse before they will get better.”" — Daniel LaCalle: On the near-term COVID trajectory despite positive vaccine headlines "“Central banks are looking at the rearview mirror.”" — Daniel LaCalle: On policy makers misreading inflation and growth risks

Implications: Listeners should expect volatility around key technical levels and policy headlines. Near-term COVID deterioration may pressure growth assets before vaccines matter, while medium-term themes favor inflation hedges, commodity exposure, and scrutiny of sovereign debt, ECB policy, and U.S. fiscal/monetary expansion.

🔓 Sign Up for Unlimited Episode Search

About Macro Voices

Weekly market commentary by Hedge Fund Manager Erik Townsend and interviews with the brightest minds in the world of finance and macroeconomics. Made possible by funding from Fourth Turning Capital Management, LLC

View all episodes from Macro Voices